Literature DB >> 10973285

A critical role for interleukin 4 in activating alloreactive CD4 T cells.

J Bagley1, T Sawada, Y Wu, J Iacomini.   

Abstract

To generate antigen-specific responses, T cells and antigen presenting cells (APCs) must physically associate with each other and elaborate soluble factors that drive the full differentiation of each cell type. Immediately after T cell activation, CD4 T cells can produce both interferon gamma (IFN-gamma) and interleukin 4 (IL-4) before polarization into distinct T helper subsets. Inhibition of IL-4 during mixed allogeneic lymphocyte culture resulted in a defect in the ability of APCs to generate sufficient costimulatory signals for activation of alloreactive T cells. In vivo, a deficiency in IL-4 production inhibited the activation of alloreactive IL-2-, IL-4- and IFN-gamma-producing CD4 T cells in mice challenged with allogeneic skin grafts, resulting in prolonged skin graft survival. Thus, production of IL-4 by CD4T cells helps activate alloreactive T cells by affecting APC function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973285     DOI: 10.1038/79811

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  13 in total

Review 1.  Impact of hyperlipidemia on alloimmunity.

Authors:  Jessamyn Bagley; Jin Yuan; John Iacomini
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

2.  Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood.

Authors:  Rachael P Jackman; Marcus O Muench; Heather Inglis; John W Heitman; Susanne Marschner; Raymond P Goodrich; Philip J Norris
Journal:  Transfusion       Date:  2016-11-18       Impact factor: 3.157

3.  Hyperlipidemia Promotes Anti-Donor Th17 Responses That Accelerate Allograft Rejection.

Authors:  J Yuan; J Bagley; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

4.  The role of IL-6 in hyperlipidemia-induced accelerated rejection.

Authors:  Linus Williams; Jessamyn Bagley; John Iacomini
Journal:  Am J Transplant       Date:  2021-10-12       Impact factor: 8.086

5.  Stellate Ganglion Block Improves the Proliferation and Function of Splenic CD4 + T Cells Through Inhibition of Posthemorrhagic Shock Mesenteric Lymph-Mediated Autophagy.

Authors:  Ying Li; Hui-Bo Du; Li-Na Jiang; Chen Wang; Meng Yin; Li-Min Zhang; Hong Zhang; Zhen-Ao Zhao; Zhan-Kuang Liu; Chun-Yu Niu; Zi-Gang Zhao
Journal:  Inflammation       Date:  2021-09-17       Impact factor: 4.092

Review 6.  Renal transplantation in the elderly.

Authors:  Ramesh Saxena; Xueqing Yu; Mauricio Giraldo; Juan Arenas; Miguel Vazquez; Christopher Y Lu; Nosratola D Vaziri; Fred G Silva; Xin J Zhou
Journal:  Int Urol Nephrol       Date:  2008-11-07       Impact factor: 2.370

7.  Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.

Authors:  Chaorui Tian; Xueli Yuan; Jessamyn Bagley; Bruce R Blazar; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2008-02-15       Impact factor: 3.969

8.  Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells.

Authors:  T Schüler; T Kammertoens; S Preiss; P Debs; N Noben-Trauth; T Blankenstein
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

9.  Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.

Authors:  P T Jindra; S Tripathi; C Tian; J Iacomini; J Bagley
Journal:  Gene Ther       Date:  2012-07-26       Impact factor: 5.250

10.  Interferon gamma enhances both in vitro and in vivo priming of CD4+ T cells for IL-4 production.

Authors:  Petr Bocek; Gilles Foucras; William E Paul
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.